Literature DB >> 17941492

Pediatric infratentorial gangliogliomas: a retrospective series.

Bertrand Baussard1, Federico Di Rocco, Matthew R Garnett, Nathalie Boddaert, Arielle Lellouch-Tubiana, Jacques Grill, Stephanie Puget, Thomas Roujeau, Michel Zerah, Christian Sainte-Rose.   

Abstract

OBJECT: The aim of this study was to retrospectively review the clinical presentation, the roles of surgery and adjuvant therapy, and the treatment-related morbidity in children with a ganglioglioma in the posterior fossa and to try and determine the prognostic factors.
METHODS: Between 1991 and 2006, 10 children were treated for a posterior fossa ganglioglioma at the authors' institution. The mean age of the children, the duration of symptoms prior to diagnosis, and the follow-up were 8.2, 2.4, and 3.9 years, respectively. Nine of the children presented with symptoms of raised intracranial pressure. Preoperative imaging showed enhancement in all patients; in eight it was in a patchy distribution. The operations consisted of radical resection (> 75%) in seven children, biopsy in two, and a total macroscopic excision in one.
RESULTS: The surgical procedure did not cause deterioration in the neurological condition in any of the children. There was no recurrence in the child who underwent total macroscopic excision of the tumor, and there has been no tumor progression in three children, two of whom have had no evidence of enhancement of the postoperative residual tumor. The tumor has progressed in six children, requiring further surgery in three, chemotherapy in four, and radiotherapy and second-line chemotherapy in one child to control the tumor.
CONCLUSIONS: The imaging of gangliogliomas in the posterior fossa showed patchy enhancement. The patients in whom it was possible to achieve a radical resection, aimed at removing at least the enhancing portion of the tumor, have not required further treatment. A second excision, for progressive tumors, is an effective adjuvant therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17941492     DOI: 10.3171/PED-07/10/286

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Comparisons of MR Findings Between Supratentorial and Infratentorial Gangliogliomas.

Authors:  X Lou; Q-P Gui; L Sun; N-Z Wu; J-H Lyu; L Ma
Journal:  Clin Neuroradiol       Date:  2014-08-23       Impact factor: 3.649

2.  Ganglioglioma in children and young adults: single institution experience and review of the literature.

Authors:  Wafik Zaky; Shekhar S Patil; Minjeong Park; Diane Liu; Wei-Lien Wang; Khalida M Wani; Susana Calle; Leena Ketonen; Soumen Khatua
Journal:  J Neurooncol       Date:  2018-06-07       Impact factor: 4.130

3.  Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes.

Authors:  Chang-Cun Pan; Xin Chen; Cheng Xu; Wen-Hao Wu; Peng Zhang; Yu Wang; Tao Wu; Jie Tang; Xin-Ru Xiao; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurooncol       Date:  2016-04-25       Impact factor: 4.130

4.  Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry.

Authors:  Michael H Chan; B K Kleinschmidt-Demasters; Andrew M Donson; Diane K Birks; Nicholas K Foreman; Sarah Z Rush
Journal:  Pediatr Blood Cancer       Date:  2012-06-15       Impact factor: 3.167

Review 5.  Pediatric infratentorial ganglioglioma.

Authors:  Stephanie Puget; Awad Alshehri; Kevin Beccaria; Thomas Blauwblomme; Giovanna Paternoster; Syril James; Federico Dirocco; Christelle Dufour; Michel Zerah; Pascale Varlet; Christian Sainte-Rose
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

6.  Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status.

Authors:  Aaron J Lindsay; Sarah Z Rush; Laura Z Fenton
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

Review 7.  Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child.

Authors:  U Löbel; D W Ellison; B L Shulkin; Z Patay
Journal:  Clin Radiol       Date:  2010-11-19       Impact factor: 2.350

8.  Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database.

Authors:  Roy W R Dudley; Michelle R Torok; Danielle R Gallegos; Jean M Mulcahy-Levy; Lindsey M Hoffman; Arthur K Liu; Michael H Handler; Todd C Hankinson
Journal:  Neurosurgery       Date:  2015-03       Impact factor: 4.654

9.  Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.

Authors:  Andrew M Donson; Bette K Kleinschmidt-DeMasters; Dara L Aisner; Lynne T Bemis; Diane K Birks; Jean M Mulcahy Levy; Amy A Smith; Michael H Handler; Nicholas K Foreman; Sarah Z Rush
Journal:  Brain Pathol       Date:  2013-12-23       Impact factor: 6.508

10.  Cerebellar ganglioglioma.

Authors:  Seong-Ho Park; Ealmaan Kim; Eun-Ik Son
Journal:  J Korean Neurosurg Soc       Date:  2008-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.